BI Asset Management Fondsmaeglerselskab A S Has $2.33 Million Holdings in Corteva, Inc. $CTVA

BI Asset Management Fondsmaeglerselskab A S increased its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 34.9% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 34,403 shares of the company’s stock after acquiring an additional 8,892 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Corteva were worth $2,327,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. NORTHSTAR ASSET MANAGEMENT Co increased its position in shares of Corteva by 2.2% in the second quarter. NORTHSTAR ASSET MANAGEMENT Co now owns 6,940 shares of the company’s stock valued at $517,000 after acquiring an additional 150 shares during the last quarter. Empirical Finance LLC boosted its position in Corteva by 0.6% during the second quarter. Empirical Finance LLC now owns 24,935 shares of the company’s stock valued at $1,858,000 after purchasing an additional 153 shares during the last quarter. Carnegie Investment Counsel grew its stake in Corteva by 3.0% in the second quarter. Carnegie Investment Counsel now owns 5,607 shares of the company’s stock valued at $418,000 after purchasing an additional 164 shares in the last quarter. United Community Bank increased its position in shares of Corteva by 10.5% during the 3rd quarter. United Community Bank now owns 1,849 shares of the company’s stock worth $125,000 after purchasing an additional 176 shares during the last quarter. Finally, Curat Global LLC increased its position in shares of Corteva by 93.7% during the 2nd quarter. Curat Global LLC now owns 370 shares of the company’s stock worth $28,000 after purchasing an additional 179 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently commented on CTVA. Royal Bank Of Canada increased their price objective on Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a report on Thursday. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a research report on Thursday. Mizuho raised their target price on shares of Corteva from $78.00 to $80.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. Wells Fargo & Company lifted their price target on Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a report on Thursday. Finally, Zacks Research upgraded Corteva from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 22nd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $82.37.

Corteva Price Performance

NYSE:CTVA opened at $72.63 on Friday. Corteva, Inc. has a 52 week low of $53.40 and a 52 week high of $77.41. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.07 and a current ratio of 1.43. The firm’s 50-day simple moving average is $68.82 and its 200 day simple moving average is $68.39. The firm has a market cap of $49.08 billion, a price-to-earnings ratio of 45.97, a P/E/G ratio of 1.84 and a beta of 0.75.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter in the previous year, the firm posted $0.32 EPS. The business’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is 45.57%.

Trending Headlines about Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Several sell‑side firms lifted targets and kept bullish ratings, signaling analyst confidence in longer‑term upside: Deutsche Bank to $90 (buy), Wolfe Research to $86 (outperform), and RBC to $89 (outperform). Deutsche Bank raise Wolfe Research raise RBC raise
• Positive Sentiment: Brokerage consensus remains constructive (consensus “Moderate Buy”), which supports demand for the shares despite near‑term noise. Consensus Moderate Buy
• Positive Sentiment: Strategic commentary highlights Corteva’s expanding role in global agriculture and technology leadership—positive for medium‑term growth expectations. Corteva expands role
• Neutral Sentiment: Analyst views are mixed across publications — some highlight long‑term upside tied to licensing and settlements, while others argue valuation limits near‑term gains. Investors should weigh catalyst timing. Bull case analysis Conflicting analyst views
• Neutral Sentiment: Technical analysis pieces warn of a key structural test — useful for traders but not definitive for fundamentals; could increase short‑term volatility. Technical caution
• Negative Sentiment: Q4 results missed revenue expectations (seasonal timing and weaker crop‑protection/seed demand); revenue miss and a wider loss drove an after‑hours selloff. Those operational misses are the main near‑term headwind. Q4 revenue miss After‑hours fall
• Negative Sentiment: JPMorgan downgraded Corteva from overweight to neutral (citing valuation/limited near‑term upside), which can cool momentum among institutional buyers. JPMorgan downgrade
• Negative Sentiment: Market reaction to the earnings miss (seasonal timing) and mixed guidance elements increases short‑term uncertainty even as analysts argue for longer‑term upside — expect higher intraday volatility. Seasonal timing impact

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.